Un cas de thrombopénie aiguë au rituximab dans la leucémie lymphoïde chronique-Reference-Cited by-同舟云学术

Un cas de thrombopénie aiguë au rituximab dans la leucémie lymphoïde chronique

Published:2017-05 Issue:5 Volume:38 Page:344-346
ISSN:0248-8663
Container-title:La Revue de Médecine Interne
language:fr
Short-container-title:La Revue de Médecine Interne

Author:

Bobot M.,Benzaquen M.,Rouby F.,Lebowitz D.,Serratrice J.,Durand J.-M.

Publisher

Elsevier BV

Subject

Gastroenterology,Internal Medicine

Reference16 articles.

1. Adverse events to monoclonal antibodies used for cancer therapy: focus on hypersensitivity responses;Baldo;Oncoimmunology,2013

2. Severe thrombocytopenia and clinical bleeding associated with rituximab infusion in a lymphoma patient with massive splenomegaly without leukemic invasion;Rigamonti;Leukemia,2001

3. Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD20 monoclonal antibody (rituximab, IDEC-C2B8);Winkler;Blood,1999

4. Rituximab therapy in hematologic malignancy patients with circulating blood tumor cells: association with increased infusion-related side effects and rapid blood tumor clearance;Byrd;J Clin Oncol,1999

5. Fatal cytokine release syndrome with chimeric anti-CD20 monoclonal antibody rituximab in a 71-year-old patient with chronic lymphocytic leukemia;Lim;J Clin Oncol,1999

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rituximab-induced acute thrombocytopenia in patients with splenomegaly B Cell lymphoma: an underdiagnosed but severe complication;Cancer Biology & Therapy;2020-10-29

2. Rituximab;Reactions Weekly;2017-09